Iwona Gawron, Magdalena Łoboda, Dorota Babczyk, Inga Ludwin, Paweł Basta, Kazimierz Pityński, Artur Ludwin
{"title":"绝经前子宫异常出血妇女子宫内膜取样中子宫内膜癌和增生的发生率。","authors":"Iwona Gawron, Magdalena Łoboda, Dorota Babczyk, Inga Ludwin, Paweł Basta, Kazimierz Pityński, Artur Ludwin","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Abnormal uterine\nbleeding (AUB) is the most common\nsymptom of endometrial cancer (EC)\nand endometrial hyperplasia with\n(AH) or without (EH) atypia. Risk of\nmalignancy and hyperplasia is significantly\nlower in premenopausal\nthan in postmenopausal women. Only\n10% of EC occurs before menopause.\nObesity and age are well-recognized\nrisk factors of endometrial cancer.\nEndometrial sampling is recommended\nin women at high risk of endometrial\nmalignancy. The primary objective\nwas to determine the incidence\nof EC, AH and EH in premenopausal\nwomen undergoing dilation and curettage\n(D&C) because of AUB. Additional\nobjective of the study was\nto estimate the risk of EC and AH in\noverweight and obese women with\ntwo types of AUB: heavy menstrual\nbleeding (AUB-HMB) and intermenstrual\nbleeding (AUB-IMB), according\nto PALM-COEIN classification.</p><p><strong>Material and methods: </strong>Retrospective\nstudy in the population of women\nundergoing D&C in tertiary hospital\nbecause of AUB between Jan-2016\nand Dec-2016. The incidence of EC,\nAH, EH was established. The influence\nof the variables: age, BMI, AUBHMB/\nAUB-IMB on the occurrence of\nabnormal histology (EC, AH, EH) was\nevaluated. Finally, the model built by\nusing backward stepwise regression\nand mechanism of v-fold cross-validation,\nshowed no statistically significant\nrelationship.</p><p><strong>Results: </strong>EC was detected in 2/213\ncases (0.9%; 95% CI 0.0003 to 0.036),\nAH in 3/213 cases (1.4%), giving a total\nof 5/213 (2.3%) women with AH or\nEC. EH was detected in 16/213 (7.5%)\nwomen. High BMI raises the chance of\nAH diagnosis: OR 1.16 (95% CI 1.05-\n1.28). The presence of HMB compared\nto IMB reduces the chance of EH: OR\n0.24 (95% CI 0.07-0.9). IMB increases\nthe chance for the diagnosis of EH 4.11 times compared to\nHMB (OR 4.1, 95% CI 1.1-14.9; p = 0.016).</p><p><strong>Conclusions: </strong>EC in premenopausal women with AUB\nundergoing D&C is rare. There is a need to search for\nmore effective methods of selection of patients than commonly\nused. Age and BMI do not seem to be factors that\nshould be used to select patients.</p>","PeriodicalId":21148,"journal":{"name":"Przeglad lekarski","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Endometrial cancer and hyperplasia rate in women before menopause with abnormal uterine bleeding undergoing endometrial sampling.\",\"authors\":\"Iwona Gawron, Magdalena Łoboda, Dorota Babczyk, Inga Ludwin, Paweł Basta, Kazimierz Pityński, Artur Ludwin\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Abnormal uterine\\nbleeding (AUB) is the most common\\nsymptom of endometrial cancer (EC)\\nand endometrial hyperplasia with\\n(AH) or without (EH) atypia. Risk of\\nmalignancy and hyperplasia is significantly\\nlower in premenopausal\\nthan in postmenopausal women. Only\\n10% of EC occurs before menopause.\\nObesity and age are well-recognized\\nrisk factors of endometrial cancer.\\nEndometrial sampling is recommended\\nin women at high risk of endometrial\\nmalignancy. The primary objective\\nwas to determine the incidence\\nof EC, AH and EH in premenopausal\\nwomen undergoing dilation and curettage\\n(D&C) because of AUB. Additional\\nobjective of the study was\\nto estimate the risk of EC and AH in\\noverweight and obese women with\\ntwo types of AUB: heavy menstrual\\nbleeding (AUB-HMB) and intermenstrual\\nbleeding (AUB-IMB), according\\nto PALM-COEIN classification.</p><p><strong>Material and methods: </strong>Retrospective\\nstudy in the population of women\\nundergoing D&C in tertiary hospital\\nbecause of AUB between Jan-2016\\nand Dec-2016. The incidence of EC,\\nAH, EH was established. The influence\\nof the variables: age, BMI, AUBHMB/\\nAUB-IMB on the occurrence of\\nabnormal histology (EC, AH, EH) was\\nevaluated. Finally, the model built by\\nusing backward stepwise regression\\nand mechanism of v-fold cross-validation,\\nshowed no statistically significant\\nrelationship.</p><p><strong>Results: </strong>EC was detected in 2/213\\ncases (0.9%; 95% CI 0.0003 to 0.036),\\nAH in 3/213 cases (1.4%), giving a total\\nof 5/213 (2.3%) women with AH or\\nEC. EH was detected in 16/213 (7.5%)\\nwomen. High BMI raises the chance of\\nAH diagnosis: OR 1.16 (95% CI 1.05-\\n1.28). The presence of HMB compared\\nto IMB reduces the chance of EH: OR\\n0.24 (95% CI 0.07-0.9). IMB increases\\nthe chance for the diagnosis of EH 4.11 times compared to\\nHMB (OR 4.1, 95% CI 1.1-14.9; p = 0.016).</p><p><strong>Conclusions: </strong>EC in premenopausal women with AUB\\nundergoing D&C is rare. There is a need to search for\\nmore effective methods of selection of patients than commonly\\nused. Age and BMI do not seem to be factors that\\nshould be used to select patients.</p>\",\"PeriodicalId\":21148,\"journal\":{\"name\":\"Przeglad lekarski\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Przeglad lekarski\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Przeglad lekarski","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
异常子宫出血(AUB)是子宫内膜癌(EC)和子宫内膜增生伴AH或不伴EH异型的最常见症状。绝经前妇女患恶性肿瘤和增生的风险明显低于绝经后妇女。只有10%的乳腺癌发生在绝经前。肥胖和年龄是公认的子宫内膜癌的危险因素。子宫内膜取样是建议子宫内膜恶性肿瘤高风险的妇女。主要目的是确定因AUB而行扩张刮除术(D&C)的绝经前妇女EC、AH和EH的发生率。该研究的另一个目的是根据PALM-COEIN分类,估计有两种AUB类型的超重和肥胖女性发生EC和AH的风险:重度月经出血(AUB- hmb)和月经间出血(AUB- imb)。材料与方法:对2016年1月至2016年12月因AUB在三级医院行D&C的女性进行回顾性研究。确定了EC、AH、EH的发病率。评估年龄、BMI、AUBHMB/AUB-IMB对异常组织学(EC、AH、EH)发生的影响。最后,通过反向逐步回归和v-fold交叉验证机制建立的模型没有统计学意义的关系。结果:2/213例中检出EC (0.9%;95% CI 0.0003 ~ 0.036), 3/213例AH(1.4%),总共5/213例(2.3%)女性患有AH orEC。213名妇女中有16名(7.5%)检出EH。高BMI增加ah诊断的机会:OR 1.16 (95% CI 1.05-1.28)。与IMB相比,HMB的存在降低了EH的机会:OR0.24 (95% CI 0.07-0.9)。与hmb相比,IMB使EH的诊断机会增加4.11倍(OR 4.1, 95% CI 1.1-14.9;P = 0.016)。结论:绝经前aub行D&C的妇女发生EC是罕见的。有必要寻找比常用的更有效的患者选择方法。年龄和体重指数似乎不应该作为选择患者的因素。
Endometrial cancer and hyperplasia rate in women before menopause with abnormal uterine bleeding undergoing endometrial sampling.
Introduction: Abnormal uterine
bleeding (AUB) is the most common
symptom of endometrial cancer (EC)
and endometrial hyperplasia with
(AH) or without (EH) atypia. Risk of
malignancy and hyperplasia is significantly
lower in premenopausal
than in postmenopausal women. Only
10% of EC occurs before menopause.
Obesity and age are well-recognized
risk factors of endometrial cancer.
Endometrial sampling is recommended
in women at high risk of endometrial
malignancy. The primary objective
was to determine the incidence
of EC, AH and EH in premenopausal
women undergoing dilation and curettage
(D&C) because of AUB. Additional
objective of the study was
to estimate the risk of EC and AH in
overweight and obese women with
two types of AUB: heavy menstrual
bleeding (AUB-HMB) and intermenstrual
bleeding (AUB-IMB), according
to PALM-COEIN classification.
Material and methods: Retrospective
study in the population of women
undergoing D&C in tertiary hospital
because of AUB between Jan-2016
and Dec-2016. The incidence of EC,
AH, EH was established. The influence
of the variables: age, BMI, AUBHMB/
AUB-IMB on the occurrence of
abnormal histology (EC, AH, EH) was
evaluated. Finally, the model built by
using backward stepwise regression
and mechanism of v-fold cross-validation,
showed no statistically significant
relationship.
Results: EC was detected in 2/213
cases (0.9%; 95% CI 0.0003 to 0.036),
AH in 3/213 cases (1.4%), giving a total
of 5/213 (2.3%) women with AH or
EC. EH was detected in 16/213 (7.5%)
women. High BMI raises the chance of
AH diagnosis: OR 1.16 (95% CI 1.05-
1.28). The presence of HMB compared
to IMB reduces the chance of EH: OR
0.24 (95% CI 0.07-0.9). IMB increases
the chance for the diagnosis of EH 4.11 times compared to
HMB (OR 4.1, 95% CI 1.1-14.9; p = 0.016).
Conclusions: EC in premenopausal women with AUB
undergoing D&C is rare. There is a need to search for
more effective methods of selection of patients than commonly
used. Age and BMI do not seem to be factors that
should be used to select patients.